Subscribe
This feature is only available for paying subscribers. You can continue reading without saving your preference, or you can subscribe now.
This feature is for paid subscribers only.
Share this profile
Copy this link
Copied!
Something went wrong.
Fast facts
- Year Founded
- 1999
Source: Sinovac Websitewww.sinovac.com/
- HQ Location
- Beijing, China
- Publicly Traded?
- Yes
Source: Nasdaqwww.nasdaq.com/market-activity/stocks/sva
- Overseas Operations
- Yes
SINOVAC primarily sells its vaccines in China while also exploring growth opportunities in international markets. In 2009, SINOVAC expanded into the global market for the first time, exporting Healive® vaccine to Mongolia and Anflu® vaccine to the Philippines. As of September 2021, more than 50 countries such as Chile, Turkey, Myanmar and Indonesia have authorized SINOVAC’s COVID-19 vaccine, CoronaVac®, for emergency use or marketing use with conditions, 6 of which have cleared it for children. CoronaVac® is also currently being manufactured in China, Brazil and Egypt.Source: 1. Sinovac Biotech Website 2. Reuters 3. Arab News
- US Sanctions
- No
- Military Affiliation in China
- No
Revenue
Source: Nasdaqwww.nasdaq.com/market-activity/stocks/sva/financials
Valuation
Valuation is reported as market capitalization. It was last updated on June 26, 2022 13:48:48.Source: Yahoo Financefinance.yahoo.com/quote/SVA/key-statistics
Employees
Source: Sinovac 2019 annual reportsec.report/Document/0001564590-20-020204/sva-20f_20191231.htm
Sinovac Biotech Ltd. is a biopharmaceutical company best known globally for its COVID-19 vaccine CoronoVac, which was the No. 1 most-used in the world as of September 2021.
CoronaVac has made up a significant proportion of the 2 billion doses administered in China and 693 million sent abroad, along with peer company Sinopharm’s shot.
Aside from its COVID-19 vaccine, Sinovac focuses on drug research, development, manufacturing, and commercialization. Based in Beijing, it also produces vaccines for hepatitis A and B, influenza, H5N1, H1N1, mumps, and canine rabies.
Source: Sinovac Websitewww.sinovac.com/Source: Reuterswww.reuters.com/article/health-coronavirus-sinovac/piecemeal-data-releases-threaten-to-undermine-sinovacs-covid-19-vaccine-idUSL4N2J80L1Source: Fortunefortune.com/2021/08/31/china-covid-vaccine-sinovac-sinopharm-delta-variant-effective/Source: FTwww.ft.com/content/91cbc7ef-808d-448a-a832-2384f045dc35Source: China Dailywww.chinadaily.com.cn/a/202109/27/WS61510727a310cdd39bc6baae.html
-
- Name
- Ownership
-
- Prime Success, L.P.
Source: Qichachawww.qcc.com/firm/l00124c3a0b13da5b60d71a0e3b5fbb7.html
- 8.25%
- Prime Success, L.P.
-
- Vivo Capital
Source: Qichachawww.qcc.com/firm/l00124c3a0b13da5b60d71a0e3b5fbb7.html
- 8.25%
- Vivo Capital
-
- CDH Utopia Limited
Source: Qichachawww.qcc.com/firm/l00124c3a0b13da5b60d71a0e3b5fbb7.html
- 8.39%
- CDH Utopia Limited
-
- 1Globe Capital LLC
Source: Qichachawww.qcc.com/firm/l00124c3a0b13da5b60d71a0e3b5fbb7.html
- 4.69%
- 1Globe Capital LLC
-
- SAIF Partners IV
Source: Qichachawww.qcc.com/firm/l00124c3a0b13da5b60d71a0e3b5fbb7.html
- 15.07%
- SAIF Partners IV
- Yin Weidong, Chairman, President, CEO
- Wang Nan, Vice President, Chief Financial Officer
- Yin Xiaomei, Vice President, Sales and marketing
- Gao Qiang, Vice President, Research and Development
- Li Jing, Vice President, Quality and Production
- Simon Anderson, Independent Director
- Yuk Lam Lo, Independent Director
- Kenneth Lee, Independent Director
- Mei Meng, Independent Director
- Fu Shan, Independent Director
Source: Sinovac 2019 Annual Reportsec.report/Document/0001564590-20-020204/sva-20f_20191231.htm
SINOVAC primarily sells its vaccines in China while also exploring growth opportunities in international markets. In 2009, SINOVAC expanded into the global market for the first time, exporting Healive® vaccine to Mongolia and Anflu® vaccine to the Philippines. As of September 2021, more than 50 countries such as Chile, Turkey, Myanmar and Indonesia have authorized SINOVAC’s COVID-19 vaccine, CoronaVac®, for emergency use or marketing use with conditions, 6 of which have cleared it for children. CoronaVac® is also currently being manufactured in China, Brazil and Egypt.
Sinovac Biotech Sanctions
While at this time it appears that this company is not the subject of any U.S. or other global sanctions, it is important to note that Chinese companies tend to have more opaque organizational structures than their Western peers. Chinese companies' affiliated brands, operating units, and overseas subsidiaries are not always obvious or even identifiable. Given this, a Chinese company may not be the subject of sanctions, but one of its subsidiaries may be, thus making it difficult to accurately ascertain a company's full sanctions status.
The latest news on Sinovac Biotech from SupChina
Foreign Affairs
Chinese vaccine diplomacy pays off with strengthened Southeast Asia ties
China and the Association of Southeast Asian Nations (ASEAN) held a meeting to mark 30 years of formal ties, and appeared to smooth over tense spots in relations — with the help of Chinese vaccine aid, which has focused on Southeast Asia.
June 8, 2021 Source: SupChina
Science & Health
China reaches 40% vaccine coverage, aims for 80% by year-end
In other Chinese vaccine news, Sinovac Biotech becomes the second China-based company to win WHO approval for its shot, and Chinese vaccine makers promise even greater supply for developing countries.
June 3, 2021 Source: SupChina
Science & Health
China domestic vaccination campaign roars ahead, now at four times peak U.S. daily rate
True to form for the world’s most populous nation, China is now administering eye-popping numbers of COVID-19 vaccinations. In a span of nine days, 100 million people in China recently received a shot.
May 18, 2021 Source: SupChina
Science & Health
WHO approves China’s Sinopharm vaccine for emergency use
Sinopharm’s COVID-19 vaccine is the first Chinese-made shot to ever be approved for emergency use by the World Health Organization. The step affirms China’s growing scientific power, but is expected to have limited impact on vaccine supply in the short term.
May 7, 2021 Source: SupChina
Science & Health
China CDC director worries about ‘not high’ vaccine efficacy, but says his remarks were taken out of context
Gao Fu, the director of China’s CDC, suggested mixing vaccines, adding doses, and looking into mRNA technology to improve the efficacy of COVID-19 shots. He later insisted that he wasn’t “admitting” to a low effectiveness of Chinese vaccines.
April 12, 2021 Source: SupChina
Domestic News
Chinese pharma’s history of counterfeits, fakes, and quality issues
In the last 20 years, Beijing has turned healthcare into a national priority. But the country's history of counterfeit drugs and weak regulation casts a lingering shadow. The topic is particularly pertinent now, with Beijing's COVID-19 vaccine diplomacy in full swing.
March 16, 2021 Source: SupChina
Foreign Affairs
The meaning of China’s vaccine diplomacy
Chinese vaccines against COVID-19 are providing low- and middle-income countries with solutions in a time of need. They have helped fill a void left by Europe and the U.S.
February 18, 2021 Source: SupChina
Science & Health
Why is China lagging behind in COVID-19 vaccinations?
China is millions of doses behind the U.S. in its COVID-19 vaccine rollout, and officials are reportedly pushing back their timeline for the first 50 million shots. Vaccine diplomacy abroad, and vaccine hesitancy at home, are slowing China’s domestic rollout.
February 9, 2021 Source: SupChina
Science & Health
What if China’s COVID-19 vaccines are the least effective?
CoronaVac, a vaccine by Sinovac Biotech, may only be a little more than 50% effective in preventing COVID-19, according to clinical trial results in Brazil. While this clears the threshold for regulatory approval, it is a disappointing result for countries that already bought tens of millions of doses of the product.
January 13, 2021 Source: SupChina
Science & Health
China ramps up COVID-19 vaccinations, approves Sinopharm shot
Chinese regulators gave approval for a mass public rollout of a COVID-19 vaccine by Sinopharm on December 30, 2020. Meanwhile, authorities worked to expand an emergency use authorization program that has already delivered millions of experimental vaccine doses.
January 4, 2021 Source: SupChina
The latest news on Sinovac Biotech from across the web
科興指接種第三針疫苗後 有症狀感染保護率增至逾八成
Third’s the charm: A third dose of Sinovac’s COVID-19 vaccine increases its protection rate for symptomatic cases from 56% to 80.2%, according to Chile’s government.
October 14, 2021 Source: std.stheadline.com
China Delays Approval of BioNTech Covid-19 Shot to Preserve Confidence in Chinese Vaccines
Health authorities worry that public doubts about Chinese vaccines stemming from approval of BioNTech’s vaccine could disrupt plans to use the homegrown shots to reach their vaccination goal before the end of the year.
August 27, 2021 Source: WSJ
China Clears Sinovac Covid-19 Vaccine for Emergency Use on Children
Asian giant becomes first major nation to approve the use of coronavirus shots on kids as young as 3 years old
July 22, 2021 Source: caixinglobal
China approves emergency use of Sinovac’s COVID-19 vaccine for children aged 3-17
China has authorized the emergency use of CoronaVac, the COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17, Sinovac Chairman Yin Weidong told the media on Friday.
July 21, 2021 Source: globaltimesnews
China Sinovac shot seen highly effective in real world study
Sinovac Biotech Ltd’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials.
July 21, 2021 Source: https://www.bangkokpost.com
Sinovac Covid Shot 50.7% Effective, Brazilian Paper Shows
The release of the study marks the first time that a Chinese-made vaccine’s late-stage trial results have been published
July 21, 2021 Source: caixinglobal
The Logic of China’s Vaccine Diplomacy
An in-depth look at where China’s vaccines are going hints at the motivations behind the campaign.
July 21, 2021 Source: thediplomat.com
Producers study vaccine efficacy on mutation with additional third-dose injection
Data collected for Chinese COVID-19 vaccines have not shown that mutated coronavirus sequences have a significant impact on the efficacy of those vaccines, but China's vaccine manufacturers are conducting follow-up experiments of their COVID-19 vaccines on the mutated strains, as some have started injecting a third shot and monitor its efficacy.
July 21, 2021 Source: globaltimesnews
Sinovac Vaccine Ruled Out as Cause of Hong Kong Woman’s Death
The city’s health authorities also said the shot wasn’t a factor in the cases of two patients in critical condition, though a second death is still pending the results of an autopsy
July 21, 2021 Source: caixinglobal
Sinovac to lift yearly production capacity to 2 billion doses by June as China expands vaccination program
Chinese vaccine producer Sinovac Biotech will expand annual production capacity to 2 billion doses by June, company CEO Yin Weidong told the Global Times on Wednesday in an exclusive interview.
July 21, 2021 Source: globaltimesnews
Philippines Begins Vaccinations With China-Donated Sinovac Shots
Country is among the last in the region to begin inoculations against Covid-19
July 21, 2021 Source: caixinglobal
Hong Kong approves Sinovac's COVID-19 vaccine for emergency use
The Hong Kong Special Administrative Region (HKSAR) government on Thursday gave nod to the emergency use of the inactivated vaccine produced by Sinovac Biotech, two days after a panel of experts recommended the vaccine to the authorities.
July 20, 2021 Source: ChinaDailyApp
Sinovac Applies for Conditional Approval of Covid-19 Vaccine in China
CoronaVac inoculation has been given to tens of thousands in China under emergency use program and has been ordered by Thailand, Singapore, Hong Kong and Brazil
July 20, 2021 Source: caixinglobal
Sinovac to Test Covid-19 Vaccine on 9,000 Health Care Workers in Brazil
Early trials in China have shown no ‘serious’ adverse responses, with nine in 10 of those inoculated producing virus-fighting antibodies
July 19, 2021 Source: caixinglobal
Coronavirus Vaccine Tracker
A look at all the vaccines that have reached trials in humans.
July 15, 2021 Source: The New York Times
Sinovac-dosed Thai health workers to get AstraZeneca booster
BANGKOK (AP) — A nighttime curfew and other new coronavirus restrictions began Monday in Thailand’s capital and several other provinces, as health officials announced that medical workers will given booster shots of AstraZeneca vaccine after already receiving two doses of China's Sinovac vaccine.
July 12, 2021 Source: AP NEWS
Thailand will give health workers a mix of Chinese and Western vaccines.
The move comes after more than 600 medical employees who had received two doses of the Sinovac vaccine became infected.
July 12, 2021 Source: The New York Times
As Delta Variant Spreads, China Lacks Data on Its Covid-19 Vaccines
The efficacy of the Chinese vaccines against the Delta variant will affect how soon China can open its borders and impact the course of the pandemic throughout much of the developing world, where many countries are reliant on Chinese shots.
July 9, 2021 Source: WSJ
Singapore excludes Sinovac from vaccine tally; South Korea cases surge
Elsewhere, South Korea reported its biggest single-day surge this year, and Thailand plans to convert an international airport terminal into a field hospital.
July 7, 2021 Source: South China Morning Post
South Africa gives green light to China’s Sinovac vaccine
The country is battling a third wave of the disease that has pushed the death toll past 60,000 and overwhelmed hospitals.
July 4, 2021 Source: South China Morning Post
Indonesia defends use of China’s Sinovac amid surge in Delta variant
Amid record highs in infections and death, Health Minister Budi Gunadi Sadikin says the problem is not the vaccine, but the mutant strain.
July 2, 2021 Source: South China Morning Post
Turkey Offers Covid-19 Booster Shot After Early Use of Chinese Vaccine
A third dose is being made available to healthcare workers and people over the age of 50 amid concerns over the spread of the highly transmissible Delta strain.
July 1, 2021 Source: WSJ
Sinovac’s COVID-19 Vaccine Found Safe for Children, Study Suggests
The trial showed that 3- to 17-year-olds had an immune response against the virus after the two-dose shot.
June 29, 2021 Source: Sixth Tone
China’s Sinovac set to start making Covid-19 jabs at Egyptian plants
Production line will begin operation soon, Chinese foreign ministry says, after Egypt’s deal with Sinovac to produce the Chinese company’s vaccine domestically.
June 28, 2021 Source: South China Morning Post
They Relied on Chinese Vaccines. Now They’re Battling Outbreaks.
More than 90 countries are using Covid shots from China. Experts say recent infections in those places should serve as a cautionary tale in the global effort to fight the disease.
June 22, 2021 Source: The New York Times
Singapore allows Sinovac shots, but casts doubt on their effectiveness.
Singapore is allowing 24 private health clinics to administer the vaccine. But it has not added it to the national vaccination program.
June 19, 2021 Source: The New York Times
Study finds ‘substantial’ antibody-level difference between BioNTech, Sinovac jab takers
Amount of antibodies does not directly reflect individual’s level of protection, but researcher notes increasing evidence that higher levels generally correspond with greater immunity against infection
June 19, 2021 Source: South China Morning Post
China’s road to 1 billion vaccine doses includes eggs, water bottles, free rides and new concern.
The enormous inoculation drive is administering 17 million shots a day. Demand has risen after a recent outbreak in the southern city of Guangzhou.
June 18, 2021 Source: The New York Times
Malaysia says China to contribute 500,000 doses of Sinovac vaccines
Malaysia's foreign minister Hishammuddin Hussein said on Wednesday China had agreed to contribute 500,000 doses of COVID-19 vaccines made by its drugmaker Sinovac BioTech (SVA.O) to the Southeast Asian country.
June 16, 2021 Source: Reuters
China Returns to Its Strict Covid Limits to Fight a New Outbreak
Foreign businesses worry that tough quarantines and restrictions could persist into next year as Beijing struggles with variants and questions about its vaccines.
June 9, 2021 Source: The New York Times
Nepal gives emergency use approval to China’s Sinovac Covid-19 vaccine
With this the number of vaccines that Nepal’s drug regulator has given approval to reaches five.
June 4, 2021 Source: kathmandupost
World Health Organization authorizes China's Sinovac Covid-19 vaccine for emergency use
The World Health Organization (WHO) has authorized a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for emergency use.
June 2, 2021 Source: CNN
WHO approves Sinovac COVID shot in second Chinese milestone
The World Health Organization (WHO) said on Tuesday it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O) for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.
June 1, 2021 Source: Reuters
China Says It Saw About 0.01% Adverse Events From Covid Vaccines
China says it saw only 119 cases of adverse events for every million doses of Covid-19 vaccines administered -- a rate that’s much lower than that reported for some western vaccines, although there’s little information on how the incidents were tracked, categorized and collated in the Asian country.
May 28, 2021 Source: Bloomberg
Indonesia's top Islamic body OKs China's Sinovac vaccine
JAKARTA, Indonesia (AP) — Indonesia's highest Islamic body on Friday gave its religious approval to China's Sinovac vaccine, paving the way for its distribution in the world's most populous Muslim nation.
May 14, 2021 Source: AP NEWS
Rodrigo Duterte Says China Covid Vaccines Won’t Affect Philippines’ Sea Claims
Philippine President Rodrigo Duterte said he will not compromise the nation’s South China Sea claims over coronavirus vaccines from China.
May 10, 2021 Source: Bloomberg
A Small Brazilian Town Is Beating Covid-19 Through a Unique Experiment
A community starts to return to normal as the pandemic continues to rage across the rest of the South American country.
May 7, 2021 Source: WSJ
Sinovac says its vaccine is safe for children as young as 3
TAIPEI, Taiwan (AP) — Sinovac said its COVID-19 vaccine is safe in children ages 3-17, based on preliminary data, and it has submitted the data to Chinese drug regulators...
April 25, 2021 Source: AP NEWS
Zimbabwe's president gets shot of Sinovac in Victoria Falls
HARARE, Zimbabwe (AP) — Zimbabwe’s president has received his first shot of the Chinese Sinovac COVID-19 vaccine, a move the government hopes will encourage more people to seek the Chinese vaccines, which are the only ones currently available in the country.
April 20, 2021 Source: AP NEWS
Sinovac supplied 260 mln COVID-19 vaccine doses globally
Sinovac Biotech (SVA.O) has supplied 260 million doses of its COVID-19 vaccine globally, with over 60% supplied to countries outside China, the company's chief executive Yin Weidong said on Tuesday.
April 20, 2021 Source: Reuters
China’s Sinovac COVID-19 vaccine 67% effective in preventing symptomatic infection - Chile govt report
China's Sinovac COVID-19 vaccine was 67% effective in preventing symptomatic infection, data from a huge real-world study inChile has shown, a potential boost for the jab which has come under scrutiny over its level of protection against the virus.
April 16, 2021 Source: Reuters
In clinical and real world trials, China’s Sinovac underperforms
The vaccine has already been exported to 19 countries | Graphic detail
April 15, 2021 Source: The Economist
Are China’s Covid Vaccines Less Effective? Experts Size Up Sinovac
The lower protection rates of China’s Covid-19 vaccines have raised concerns about shots that are key to inoculation rollouts from Brazil to Indonesia, especially after their efficacy was questioned by one of the most senior Chinese health officials.
April 13, 2021 Source: Bloomberg
Turkey says China's Sinovac vaccine is 'significantly effective'
Study of inoculated elderly and health workers shows halving of positive cases
April 13, 2021 Source: Nikkei Asia
Philippines Asks U.S. for Vaccine Help as China Tensions Grow
The Philippines will restart military drills with the U.S. on Monday as the Southeast Asian nation seeks to speed up vaccine deliveries from its longtime defense ally.
April 12, 2021 Source: Bloomberg
Chile Covid-19 vaccination drive adds to Sinovac efficacy data
As the country grapples with rising infections, results from its vaccinated population echo Brazil’s trial of the Chinese jab.
April 9, 2021 Source: South China Morning Post
Egypt to produce up to 80 million Sinovac vaccine doses annually - minister
Egypt has agreed with China's Sinovac Biotech Ltd to manufacture its COVID-19 vaccine domestically, and could produce up to 80 million doses a year, the health ministry said on Thursday.
April 8, 2021 Source: U.S.
China’s Bid to Ramp Up Vaccinations Hindered by Supply Shortages
China’s ambitious effort to vaccinate 560 million people -- 40% of its population -- by the end of June is running into a supply shortage, forcing health authorities to extend the intervals between two doses, and leaving some people unable to book their second shots.
April 8, 2021 Source: Bloomberg
China to donate 150,000 Sinovac COVID-19 vaccine doses to El Salvador
El Salvador's President Nayib Bukele said on Sunday that China will donate 150,000 Sinovac COVID-19 vaccine doses to the Central American nation, on top of the 2 million Sinovac jabs his government already purchased.
April 4, 2021 Source: U.S.
China Sinovac says it reached two billion doses annual capacity for COVID-19 vaccine
China's Sinovac Biotech said on Friday its third production plant for its COVID-19 vaccine was ready and had started manufacturing procedures for bulk vaccine ingredient, doubling its annual capacity to 2 billion doses.
April 2, 2021 Source: U.S.
China’s CanSino Says European Vaccine Order Talks Are Underway
CanSino Biologics Inc. said it’s in talks with a number of European countries about orders for its Covid-19 vaccine, which if signed would mark the first recognition of Chinese drugmakers’ inoculations in the developed world amid concerns over their relative lack of data disclosure.
March 25, 2021 Source: Bloomberg
Ukraine procurement agency says cannot accept first batch of China's Sinovac vaccine
Ukraine's state Medical Procurement Agency (MPA) said on Wednesday it cannot accept the first batch of China's Sinovac COVID-19 vaccine because the supplier did not provide the required documents.
March 24, 2021 Source: U.S.
Egypt aims for deal to produce Sinovac COVID-19 vaccines
The Egyptian government hopes to sign an agreement with China's Sinovac Biotech Ltd before the end of March to manufacture its coronavirus vaccine in Egypt, Health Minister Hala Zayed said on Monday.
March 22, 2021 Source: U.S.
Mexico gets shipment of million vaccine doses from China's Sinovac
Mexico received a shipment of a million doses of the COVID-19 vaccine by China's Sinovac Biotech Ltd, the foreign ministry said on Twitter on Saturday.
March 13, 2021 Source: U.S.
Covid-19: Hongkongers' demand for Sinovac vaccination wanes as third man in critical condition within days of jab | Hong Kong Free Press HKFP
The percentage of people who have not shown up for their booked vaccination appointments at eight government-run community centres administering the Sinovac vaccine has more than tripled in the past four days. Official figures show a steady rise in people not turning up for vaccination from 11 per cent last Saturday to 36 per cent […]
March 10, 2021 Source: Hong Kong Free Press HKFP
Ukraine approves China's Sinovac COVID-19 vaccine
Ukraine has approved the COVID-19 vaccine developed by China's Sinovac, the health ministry said on Tuesday.
March 9, 2021 Source: U.S.
Study of Aggressive Covid-19 Strain in Brazil Suggests Limits of China Vaccine
A small-scale study found plasma from eight people vaccinated with CoronaVac failed to efficiently neutralize the Amazonian strain of the coronavirus known as P.1 that is now ravaging Brazil.
March 6, 2021 Source: WSJ
Turkish Trials Show China’s Sinovac Shot to Be 83.5% Effective
Turkish trials found China’s Sinovac inoculation to be 83.5% effective against the coronavirus, a level of protection that’s lower than the country’s initial predictions but significantly above Brazilian estimates.
March 3, 2021 Source: Bloomberg
Malaysia Receives China’s Sinovac Vaccine For Regulatory Testing
Malaysia received China’s Sinovac vaccine on Saturday, the second brand of Covid-19 shots days after the Southeast Asian country kicked off its inoculation program.
February 27, 2021 Source: Bloomberg
Hong Kong leader gets China's Sinovac vaccine to bolster public confidence
Hong Kong's leader Carrie Lam received China's Sinovac vaccine on Monday together with top officials at a live televised event to bolster public confidence ahead of the vaccine's rollout in the global financial hub this week.
February 22, 2021 Source: U.S.
Hong Kong advisory panel approves China's Sinovac COVID-19 vaccine for emergency use
A Hong Kong government advisory panel on COVID-19 vaccines said on Tuesday it would recommend China's Sinovac vaccine for emergency use, a move that brings it a step closer to being formally greenlighted in the Asian financial hub.
February 16, 2021 Source: U.S.
China’s Covid-19 Vaccine Diplomacy Boosts Its Influence in Europe
Frustrated by rollout stumbles on the continent, some small European countries are turning to Beijing for help fighting Covid-19, a trend that could expand China’s presence in a strategically important region.
February 13, 2021 Source: WSJ
Sinovac’s COVID-19 Vaccine Second to Secure Approval in China
The authorization comes just over a month after the country granted conditional approval for a vaccine developed by state-owned firm Sinopharm.
February 7, 2021 Source: Sixth Tone
Exclusive: Indonesia approves China's Sinovac vaccine for the elderly
Indonesia has approved Sinovac Biotech's COVID-19 vaccine for use in the elderly, a letter from the food and drug agency shows, potentially changing the country's strategy which has prioritised its working population first.
February 6, 2021 Source: U.S.
China Approves Sinovac Vaccine for Broad Use Against Covid-19
The country’s drug regulator has given provisional approval to a Covid-19 vaccine developed by Chinese drugmaker Sinovac Biotech, which has faced questions over its vaccine efficacy due to a lack of transparency around clinical trial data.
February 6, 2021 Source: WSJ
China approves Sinovac Biotech COVID-19 vaccine for general public use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been approved for use by the general public by China's medical products regulator.
February 6, 2021 Source: U.S.
Mexico gets China's Sinovac vaccine paperwork for approval
MEXICO CITY (AP) — Mexico announced Friday that Sinovac, the Chinese manufacturer of the CoronaVac vaccine, has submitted paperwork for approval in Mexico. Another Chinese firm, CanSino, has...
February 5, 2021 Source: AP NEWS
Power, Patriotism and 1.4 Billion People: How China Beat the Virus and Roared Back
The Chinese Communist Party reached deep into private business and the broader population to drive a recovery, an authoritarian approach that has emboldened its top leader, Xi Jinping.
February 5, 2021 Source: The New York Times
China’s Sinopharm, Sinovac Covid-19 vaccines assessed by WHO for emergency use
WHO reviews the firms for ‘emergency use listing’, which could expedite their approval by countries’ regulators, with a decision expected in March at earliest.
January 27, 2021 Source: South China Morning Post
China Wanted to Show Off Its Vaccines. It’s Backfiring.
Delays, inconsistent data, spotty disclosures and the country’s attacks on Western rivals have marred its ambitious effort to portray itself as a leader in global health.
January 25, 2021 Source: The New York Times
Moderna Lags China's Sinovac, Sinopharm in WHO Covid Vaccine Approval
As concern over vaccine disparity across the world deepens, the World Health Organization is struggling to keep pace with rich western countries in green-lighting shots for use -- slowing down the Covax initiative which poorer countries are relying on for inoculation.
January 22, 2021 Source: Bloomberg
Sinovac Steps Up Defense of Shot After Confusing Data
China’s Sinovac Biotech Ltd. defended the efficacy of its Covid-19 shot, saying the vaccine that’s being rolled out from Indonesia to Brazil despite inconsistent data readouts is more effective in preventing the disease if the two-dose regime is administered over a longer time frame.
January 18, 2021 Source: Bloomberg
Brazil Turns to Chinese Covid Vaccine as Cases Surge
Two top politicians clash over response as the country’s average death toll approaches 1,000 people a day.
January 17, 2021 Source: WSJ
Two senior managers from one of China's top vaccine companies have resigned
Sinopharm, a state-owned giant behind China's coronavirus vaccine development, announced its chairman left the board as of Tuesday.
January 15, 2021 Source: CNBC
Bio Farma sets sights on making China’s Sinovac vaccines for Asean
The Indonesian firm began life 130 years ago in the Dutch colonial era. Several world class vaccines and a few name changes later, it is fighting both Covid-19 and a sceptical public.
January 15, 2021 Source: South China Morning Post
How Effective Is China’s Sinovac Shot? Covid Vaccine Data Unclear
Days before a global rollout kicks off with the President of Indonesia receiving the Sinovac Biotech Ltd. vaccine on live television, uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks.
January 12, 2021 Source: Bloomberg
Philippines secures 25m doses of Sinovac COVID vaccine
Country hopes to inoculate two-thirds of its population this year
January 11, 2021 Source: Nikkei Asia
Indonesia approves China's Sinovac vaccine as infections surge
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
January 11, 2021 Source: U.S.
Brazil Embraces Chinese Covid-19 Vaccine as Cases Soar
Brazilian President Jair Bolsonaro’s administration has backed down from its criticism of Chinese vaccines and agreed to buy up to 100 million doses of a shot being developed by China’s Sinovac, as Latin America confronts a postholiday surge in Covid-19 cases.
January 8, 2021 Source: WSJ
A Second Chinese Coronavirus Vaccine Is Said to Be Effective
Sinovac Biotech has sold more than 300 million doses to the developing world, filling a gap left by Western countries.
January 7, 2021 Source: The New York Times
Ukraine signs up for China's Sinovac vaccine, with doses expected soon
Ukraine has signed contract to buy 1.8 million doses of China's Sinovac COVID-19 vaccine, the presidential office said on Wednesday, with the shots expected in "the shortest possible time".
December 30, 2020 Source: U.S.
China Has All It Needs to Vaccinate Millions, Except Any Approved Vaccines
Across the country, local governments plan to inoculate 50 million people against the coronavirus by early next year. But the vaccines have not officially been approved.
December 29, 2020 Source: The New York Times
China’s Struggling to Get the World to Trust Its Covid Vaccines
What should have been a big Covid win for Beijing in building ties is revealing widespread mistrust in China’s products.
December 28, 2020 Source: Bloomberg
China Shot’s Efficacy Uncertain After Brazil, Turkey Results
With trials of Sinovac Biotech Ltd.’s coronavirus vaccine in Brazil and Turkey suggesting the shot has a protection rate on either side of 90%, there is still no final assessment on exactly how effective it is in protecting people against Covid-19.
December 25, 2020 Source: Bloomberg
Brazil says Sinovac vaccine over 50% effective but delays full results
Chinese developer's request to withhold detailed data raises questions
December 24, 2020 Source: Nikkei Asia
China to Vaccinate 50 Million People With Its Covid-19 Shots
China is expanding an already considerable rollout of its leading Covid-19 vaccine candidates.
December 18, 2020 Source: WSJ
Hong Kong to receive Covid-19 vaccine from China's Sinovac in January, Pfizer version to follow | Hong Kong Free Press HKFP
Hong Kong will receive its first batch of coronavirus vaccines as early as next month with the elderly and medical staff to get priority in a free mass vaccination government programme, Chief Executive Carrie Lam said on Friday. Lam said city authorities in a “breakthrough” had secured 15 million shots through advance purchase deals with […]
December 11, 2020 Source: Hong Kong Free Press HKFP
As China nears a coronavirus vaccine, bribery cloud hangs over drugmaker Sinovac
CEO gave cash bribes to a Chinese drug regulatory official for nine years, aiding the company’s climb to the top of the country’s vaccine industry, court records show.
December 4, 2020 Source: Washington Post
Brazil to receive China's Sinovac COVID-19 vaccine, eyes Pfizer candidate
Brazil's Sao Paulo state is set to begin importing the first of 46 million doses of China's Sinovac vaccine against COVID-19 this week, while the federal government takes a more cautious approach with a vaccine developed by Pfizer Inc.
November 17, 2020 Source: U.S.
Vaccine Unproven? No Problem in China, Where People Scramble for Shots
Many say they are reassured because politicians and executives have been inoculated. But experts say the risks outweigh the benefits.
November 17, 2020 Source: The New York Times
In Brazil’s Halt of Chinese Vaccine Trial, Critics See Politics
The government offered little explanation as to why it had stopped testing a promising coronavirus shot; an institute involved in the trial said a participant’s death was unrelated to the vaccine.
November 10, 2020 Source: The New York Times
Sao Paulo starts building production plant for China's Sinovac vaccine: governor
The Brazilian state of São Paulo has begun building a facility to produce 100 million doses a year of China's Sinovac vaccine against COVID-19, which will be ready by September next year, Governor João Doria said on Monday.
November 9, 2020 Source: U.S.
Brazil's Bolsonaro rejects plan to buy China's Sinovac vaccine; health minister tests positive
Brazil's President Jair Bolsonaro said on Wednesday the federal government will not buy a COVID-19 vaccine from China's Sinovac, one day after the health minister said it would be included in the nation's immunization program.
October 21, 2020 Source: U.S.
China Defends Giving Experimental Vaccines to Thousands
China said giving coronavirus vaccines still being tested to hundreds of thousands of people outside of clinical trials is justified given the risk of Covid-19 returning through its borders and the lack of any significant side-effects so far from the shots.
October 20, 2020 Source: Bloomberg
China's Sinovac vaccine is safe, Brazil institute says
An experimental coronavirus vaccine developed by China's Sinovac Biotech appeared to be safe in a late-stage clinical trial in Brazil, preliminary results showed on Monday.
October 19, 2020 Source: U.S.
Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60
(This October 16 story was refiled to correct spelling of city Jiaxing in 4th paragraph)
October 16, 2020 Source: U.S.
Sinovac vaccine trial said to be stalled in Bangladesh over funding
Phase 3 test of CoronaVac uncertain after drug company asked government to co-finance it, according to local media reports citing health secretary.
October 6, 2020 Source: South China Morning Post
China's Sinovac to test coronavirus vaccine candidate in teenagers, children
Chinese vaccine maker Sinovac Biotech plans to start a clinical trial of its experimental coronavirus vaccine with children and adolescents later this month, widening its test on a shot that's already in the final stage of study with adults.
September 17, 2020 Source: U.S.
Covid Pandemic: Why Indonesia Became Testing Ground for China’s Covid-19 Vaccine
The country is home to Asia’s second-worst Covid-19 outbreak, and it’s eager to take the risks.
September 15, 2020 Source: Bloomberg